More recently, signaling from γc cytokines has been seen to drive metabolic remodeling in T cells in mouse models of aging, inflammation, and lymphopenia (13–15), but the impact of lymphopenia-inducing therapies on T cell metabolism in aged humans has not been defined. Here, GC is linked to lymphopenia.